Randomized Withdrawal Study in Patients With Schizophrenia
Study sponsor: Vanda Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-11Estimated
Enrollment · participants400Estimated
Source updated2026-01-12Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.